Elicio Therapeutics, Inc. (ELTX) Net margin 2020–2022
Elicio Therapeutics, Inc. (ELTX) net profit margin by fiscal year — reported net income divided by reported revenue.
-1225.9%FY2022 · since FY2020: -2781.5% → -1225.9%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2022 | -1225.9% | -1033.1 pp |
| FY2021 | -192.8% | +2588.7 pp |
| FY2020 | -2781.5% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More ELTX financial trends
ELTX RevenueELTX Net incomeELTX Gross profitELTX Gross marginELTX Operating incomeELTX Operating marginELTX Operating cash flowELTX Free cash flowELTX Capital expendituresELTX Return on equityELTX Stock buybacksELTX Dividends paidELTX Total assetsELTX Total liabilitiesELTX Shareholders’ equityELTX overview →